» Articles » PMID: 9582503

Culture of Human Insulinoma Cells: Development of a Neuroendocrine Tumor Cell- and Human Pancreatic Islet Cell-specific Monoclonal Antibody

Overview
Journal J Endocrinol
Specialty Endocrinology
Date 1998 May 16
PMID 9582503
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We report on the culture of human insulinoma cells derived from a 32-year-old male patient with hyperinsulinism due to an insulinoma of the pancreas. A single-cell suspension was made by passing insulinoma fragments through a fine-gauge stainless-steel mesh. Cluster-forming insulinoma cells resembling pancreatic islets grew in the presence of fibroblasts. The insulinoma cell clusters could be differentiated from fibroblasts by using in situ pan optic staining and specific immunocytochemical staining (anti-human insulin and anti-human insulinoma monoclonal antibody (mAb) D24). mAb D24 was generated using insulinoma cells as antigen for immunization of a Balb/C mouse and cell fusion by the hybridoma cell technique. The anti-insulinoma cell mAb recognized a 32 kDa protein on immunoblot analysis of neuroendocrine tumor cells. D24 mAb also reacted immunohistochemically with normal pancreatic beta-cells and tumors such as vipoma, gastrinoma and carcinoid. Insulinoma cell clusters separated from fibroblasts by micromanipulation and plated into multiwell culture dishes exhibited an insulin-secretion rate of approximately 30 U/100 cells per 24 h with no insulin-secretory response to elevated glucose concentration. Purified insulinoma cells incubated with 1 ng/ml human nerve growth factor expressed neurofilament and neurite extension. These findings together with earlier observations in animal models suggest that human pancreatic beta-cells share some properties with neurons and are related to other neuroendocrine cells in the gastrointestinal tract.

Citing Articles

Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin.

Juhlin C, Zedenius J, Hoog A Endocr Pathol. 2020; 31(4):401-410.

PMID: 32813226 PMC: 7665972. DOI: 10.1007/s12022-020-09645-y.


20 Years of Secretagogin: Exocytosis and Beyond.

Maj M, Wagner L, Tretter V Front Mol Neurosci. 2019; 12:29.

PMID: 30853888 PMC: 6396707. DOI: 10.3389/fnmol.2019.00029.


[Location and functions of secretagogin protein].

Liu Q, Lai M Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016; 45(1):56-60.

PMID: 27045242 PMC: 10396990. DOI: 10.3785/j.issn.1008-9292.2016.01.09.


[Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].

Xu F, Liu Q, Han F, Xu E, Lai M, Zhao Z Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016; 45(1):24-30.

PMID: 27045237 PMC: 10400834. DOI: 10.3785/j.issn.1008-9292.2016.01.04.


Secretagogin is expressed in sensory CGRP neurons and in spinal cord of mouse and complements other calcium-binding proteins, with a note on rat and human.

Shi T, Xiang Q, Zhang M, Tortoriello G, Hammarberg H, Mulder J Mol Pain. 2012; 8:80.

PMID: 23102406 PMC: 3560279. DOI: 10.1186/1744-8069-8-80.